Skip to content Skip to navigation

Collaborators

The Priest Lab is proud to maintain collaborations and partnerships with the following laboratories.
Portrait of Dr. Quertermous in his laboratory

Thomas Quertermous

The Quertermous laboratory is interested in the molecular mechanisms that mediate vascular disease pathophysiology and the risk for these diseases. Their approach is primarily genetic, using human cohorts and large scale genome wide studies to identify genes that associate with disease and risk, and molecular genetic studies used to define the mechanisms of these associations.
Portrait of Dr. Ashley

Euan Ashley

The Ashley lab is focused on the application of genomics to medicine. Specifically, they develop methods for the interpretation of whole genome sequencing data to improve diagnosis of genetic disease and to personalize the practice of medicine. Their group includes grad students, post docs, MDs and genetic counselors. They also lead the Stanford Center for Inherited Cardiovascular Disease.
Portrait of Dr. Ingelsson

Erik Ingelsson

For the past ten years, Dr. Ingelsson has been interested in the link between metabolic disturbances, such as obesity and insulin resistance, and the development of subclinical and clinical cardiovascular diseases. His research is translational and interdisciplinary, combining methods from the molecular epidemiology field – such as genomic, metabolomic, transcriptomic, epigenomic, and proteomic profiling in large population-based studies – with in vivo and in vitro work to reach new insights into the pathophysiology of cardiovascular disease and related conditions. His lab aims to identify new biomarkers for improved risk prediction, and to discover novel targets for drug development.
Portrait of Dr. Shaw

Gary Shaw

Dr. Shaw's research interests include the epidemiology of birth defects, gene-environment approaches to perinatal outcomes, and the relationship between nutrition and reproductive outcomes. He currently serves as Co-PI of the March of Dimes Prematurity Research Center at Stanford, and as PI of the California Center Finding Causes and Prevention of Birth Defects.
Photo of Dr. Gelb

Bruce Gelb

In his quest to discover what causes congenital heart disease, Bruce D. Gelb, MD, has developed an extensive program in genomics and gene investigation, focusing on traits associated with heart malformations. An expert in Noonan syndrome, Dr. Gelb has studied the genetic origins of this disease to understand its pathogenesis. At The Mindich Child Health and Development Institute, Dr. Gelb has created a collaborative multidisciplinary research environment to advance translational research into prevalent diseases of childhood. The emphasis is on the application of genetics and genomics toward elucidating the causes of illness affecting infants, children, and adolescents.
Portrait of Dr. Knowles

Josh Knowles

The fundamental theme of Dr. Knowles's work is the application of genetics to improve human health. He views this concept as a continuum from Discovery, to the development of Model Systems, to clinical Translation, to larger Public Health efforts. Much of his work focuses on the discovery of genetic variants underlying cardiovascular disease, particularly coronary disease and insulin resistance through large international studies.